358
Views
8
CrossRef citations to date
0
Altmetric
Methodology

Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)

ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon, , , & ORCID Icon show all
Pages 971-983 | Published online: 09 Jun 2020

References

  • Cheen MHH, Tan YZ, Oh LF, Wee HL, Thumboo J. Prevalence of and factors associated with primary medication non-adherence in chronic disease: a systematic review and meta-analysis. Int J Clin Pract. 2019;73(6):e13350. doi:10.1111/ijcp.13350
  • Conn VS, Enriquez M, Ruppar TM, Chan KC. Meta-analyses of theory use in medication adherence intervention research. Am J Health Behav. 2016;40(2):155–171. doi:10.5993/AJHB.40.2.1
  • Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017;99:269–276. doi:10.1016/j.ypmed.2017.03.008
  • Conn VS, Ruppar TM, Enriquez M, Cooper P. Medication adherence interventions that target subjects with adherence problems: systematic review and meta-analysis. Res Social Adm Pharm. 2016;12(2):218–246. doi:10.1016/j.sapharm.2015.06.001
  • Gast A, Mathes T. Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst Rev. 2019;8(1):112. doi:10.1186/s13643-019-1014-8
  • Christiansen AJ. Patient Adherence to Medical Treatment Regimens. New Heaven, CT: Yale University Press; 2004.
  • Organization WH. Adherence to long-term therapies: evidence for action. World Health Organization; 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed June 10, 2019.
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
  • Rapoff M. Adherence to pediatric medical regimens. In: Issues in Clinical Child Psychology. 2nd ed. New York: Springer Science+Business Media; 2010.
  • Mira JJ, Orozco-Beltrán D, Pérez-Jover V, et al. Physician patient communication failure facilitates medication errors in older polymedicated patients with multiple comorbidities. Fam Pract. 2012;30(1):56–63. doi:10.1093/fampra/cms046
  • Bailey SC, Opsasnick LA, Curtis LM, et al. Longitudinal investigation of older adults’ ability to self-manage complex drug regimens. J Am Geriatr Soc. 2019. doi:10.1111/jgs.16255
  • McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868–2879. doi:10.1001/jama.288.22.2868
  • Urquhart J, De Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med. 1998;17(3):251–267; discussion 387–259. doi:10.1002/(SICI)1097-0258(19980215)17:3<251::AID-SIM762>3.0.CO;2-A
  • Cheetham TC, Niu F, Green K, et al. Primary nonadherence to statin medications in a managed care organization. J Manag Care Pharm. 2013;19(5):367–373. doi:10.18553/jmcp.2013.19.5.367
  • Latry P, Pinet M, Labat A, et al. Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clin Ther. 2008;30:Spec No:1058–1068. doi:10.1016/j.clinthera.2008.06.011
  • Badawy SM, Thompson AA, Penedo FJ, Lai J-S, Rychlik K, Liem RI. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease. Eur J Haematol. 2017;98(6):608–614.
  • Badawy SM, Thompson AA, Liem RI. Beliefs about hydroxyurea in youth with sickle cell disease. Hematol Oncol Stem Cell Ther. 2018;11(3):142–148. doi:10.1016/j.hemonc.2018.01.001
  • Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117(8):1028–1036. doi:10.1161/CIRCULATIONAHA.107.706820
  • Lee JS, Joyce G, McCombs J. Outcomes associated with primary and secondary nonadherence to cholesterol medications. Am J Pharm Benefits. 2016;8(2):54–60.
  • Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. doi:10.1136/bmj.38875.675486.55
  • Badawy SM, Thompson AA, Lai JS, Penedo FJ, Rychlik K, Liem RI. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease. Pediatr Blood Cancer. 2017;64(6):e26369. doi:10.1002/pbc.26369
  • DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811. doi:10.1097/00005650-200209000-00009
  • Europe Fo. Just what the doctor ordered: an EU response to medication nonadherence. Friends of Europe; 2010. Available from: https://www.friendsofeurope.org/. Accessed June 11, 2019.
  • Efficace F, Rosti G, Cottone F, et al. Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitors. Leuk Res. 2014;38(3):294–298. doi:10.1016/j.leukres.2013.07.003
  • Badawy SM, Thompson AA, Kuhns LM. Medication adherence and technology-based interventions for adolescents with chronic health conditions: a few key considerations. JMIR Mhealth Uhealth. 2017;5(12):e202. doi:10.2196/mhealth.8310
  • Badawy SM, Barrera L, Sinno MG, Kaviany S, O’Dwyer LC, Kuhns LM. Text messaging and mobile phone apps as interventions to improve adherence in adolescents with chronic health conditions: a systematic review. JMIR Mhealth Uhealth. 2017;5(5):e66. doi:10.2196/mhealth.7798
  • Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11(1):149. doi:10.1186/1471-2288-11-149
  • Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:12. doi:10.1155/2015/217047
  • Cleemput I, Dobbels F. Measuring patient-reported outcomes in solid organ transplant recipients. PharmacoEconomics. 2007;25(4):269–286. doi:10.2165/00019053-200725040-00002
  • Nguyen T-M-U, Caze AL, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2014;77(3):427–445. doi:10.1111/bcp.12194
  • Kim C-J, Schlenk EA, Ahn J-A, Kim M, Park E, Park J. Evaluation of the measurement properties of self-reported medication adherence instruments among people at risk for metabolic syndrome: a systematic review. Diabetes Educ. 2016;42(5):618–634. doi:10.1177/0145721716655400
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
  • Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
  • Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–1194. doi:10.1016/j.jclinepi.2010.04.011
  • Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl 1):S3–S11. doi:10.1097/01.mlr.0000258615.42478.55
  • DeWalt DA, Rothrock N, Yount S, Stone AA, Group PC. Evaluation of item candidates: the PROMIS qualitative item review. Med Care. 2007;45(5 Suppl 1):S12–S21. doi:10.1097/01.mlr.0000254567.79743.e2
  • Hahn EA, Devellis RF, Bode RK, et al. Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res. 2010;19(7):1035–1044. doi:10.1007/s11136-010-9654-0
  • Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 Suppl 1):S22–S31. doi:10.1097/01.mlr.0000250483.85507.04
  • PROMIS Cooperative Group. PROMIS® instrument development and validation scientific standards version 2.0; 2013. Available from: http://www.healthmeasures.net/images/PROMIS/PROMISStandards_Vers2.0_Final.pdf. Accessed May 11, 2019, 2019.
  • Cella D, Choi SW, Condon DM, et al. PROMIS((R)) adult health profiles: efficient short-form measures of seven health domains. Value Health. 2019;22(5):537–544. doi:10.1016/j.jval.2019.02.004
  • Chlebowski RT, Kim J, Haque R. Adherence to endocrine therapy in breast cancer adjuvant and prevention settings. Cancer Prev Res. 2014;7(4):378. doi:10.1158/1940-6207.CAPR-13-0389
  • Lehmann A, Aslani P, Ahmed R, et al. Assessing medication adherence: options to consider. Int J Clin Pharm. 2014;36(1):55–69. doi:10.1007/s11096-013-9865-x
  • Bissonnette JM. Adherence: a concept analysis. J Adv Nurs. 2008;63(6):634–643. doi:10.1111/j.1365-2648.2008.04745.x
  • Culig J, Leppée M. From Morisky to hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol. 2014;38(1):55–62.
  • Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc. 2011;51(1):90–94. doi:10.1331/JAPhA.2011.09154
  • Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–482. doi:10.1007/s13142-015-0315-2
  • Murray MD, Morrow DG, Weiner M, et al. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother. 2004;2(1):36–43. doi:10.1016/S1543-5946(04)90005-0
  • Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64(3):250–254. doi:10.1016/j.jclinepi.2010.07.014
  • Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever RQ. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacother. 2009;43(10):1621–1630. doi:10.1345/aph.1M174
  • Wu JR, Chung M, Lennie TA, Hall LA, Moser DK. Testing the psychometric properties of the medication adherence scale in patients with heart failure. Heart Lung. 2008;37(5):334–343. doi:10.1016/j.hrtlng.2007.10.001
  • Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61(3):282–288. doi:10.1016/j.jclinepi.2007.04.007
  • Breuil V, Cortet B, Cotte FE, et al. Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporos Int. 2012;23(2):445–455. doi:10.1007/s00198-011-1555-8
  • Feldman BJ, Fredericksen RJ, Crane PK, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2013;17(1):307–318. doi:10.1007/s10461-012-0326-7
  • Knobel H, Alonso J, Casado JL, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS. 2002;16(4):605–613. doi:10.1097/00002030-200203080-00012
  • Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59(1):13–20.
  • Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health. 2009;12(1):118–123. doi:10.1111/j.1524-4733.2008.00400.x
  • Voils CI, Maciejewski ML, Hoyle RH, et al. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care. 2012;50(12):1013–1019. doi:10.1097/MLR.0b013e318269e121
  • Gruber-Baldini AL, Velozo C, Romero S, Shulman LM. Validation of the PROMIS((R)) measures of self-efficacy for managing chronic conditions. Qual Life Res. 2017;26(7):1915–1924. doi:10.1007/s11136-017-1527-3
  • Pearman TP, Beaumont JL, Mroczek D, O’Connor M, Cella D. Validity and usefulness of a single‐item measure of patient‐reported bother from side effects of cancer therapy. Cancer. 2018;124(5):991–997. doi:10.1002/cncr.31133
  • de Souza JA, Yap BJ, Hlubocky FJ, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014;120(20):3245–3253.
  • Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998;32(7–8):749–754.
  • Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest. 2011;140(2):425–432. doi:10.1378/chest.09-3074
  • Myaskovsky L, Jesse MT, Kuntz K, et al. Report from the American Society of Transplantation Psychosocial Community of Practice Adherence Task Force: real-world options for promoting adherence in adult recipients. Clin Transplant. 2018;32(9):e13353.
  • Maldonado AQ, West-Thielke P, Dew MA, et al. Meeting report: consensus recommendations for a research agenda to address immunosuppressant nonadherence in organ transplantation. Clin Transplant. 2018;32(9):e13362.
  • Edelen MO, Reeve BB. Applying item response theory (IRT) modeling to questionnaire development, evaluation, and refinement. Qual Life Res. 2007;16:5–18.
  • Hays RD, Morales LS, Reise SP. Item response theory and health outcomes measurement in the 21st century. Med Care. 2000;38(9 Suppl):II28–II42.
  • Cappelleri JC, Jason Lundy J, Hays RD. Overview of classical test theory and item response theory for the quantitative assessment of items in developing patient-reported outcomes measures. Clin Ther. 2014;36(5):648–662.
  • Fries JF, Bruce B, Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol. 2005;23:S53.
  • Schalet BD, Hays RD, Jensen SE, Beaumont JL, Fries JF, Cella D. Validity of PROMIS physical function measured in diverse clinical samples. J Clin Epidemiol. 2016;73:112–118.
  • Liu H, Cella D, Gershon R, et al. Representativeness of the patient-reported outcomes measurement information system internet panel. J Clin Epidemiol. 2010;63(11):1169–1178.